Peng Zhang, MD

Sichuan Cancer Hospital and Institute
Chengdu, Sichuan

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 2930 - Impacts of Combining Anti-PD-1 Immunotherapy and PLDR on the Tumour Immune Microenvironment in a Murine Lung Cancer Model

  Monday, September 30, 2024
  5:00 PM – 6:00 PM ET

• 3662 - Multi-Sequence MRI Based Metachronous Single-Organ Metastasis Prediction of Nasopharyngeal Carcinoma

  Wednesday, October 2, 2024
  10:30 AM – 11:45 AM ET